Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction

Summary

In the present study, we explored the microparticles involved in the control of hemostatic equilibrium, i.e microparticles originating from platelet, endothelial cells and total MP defined as annexin V positive microparticles. Our aim was to analyze the level and procoagulant activity of these microparticles in normal pregnancy and pregnancies complicated with preeclampsia or isolated intrauterine growth restriction. We reported increased levels of platelet and endothelial microparticles in normal pregnancy compared to non pregnant healthy women. Number of annexin V microparticles was significantly increased together with their procoagulant activity. In pathological pregnancies, significant reduction in platelet microparticle number was found in preeclampsia. The procoagulant activity generated by the total annexin V MP was unchanged, suggesting that the microparticles remaining in the circulation were pro-coagulant. This study evidenced that microparticles constitute a cellular marker of a proinflammatory and procoagulant responses in normal pregnancy. In pregnancies with vascular complications, circulating MP with procoagulant potential may be part of the exacerbation of these responses.

Keywords

Pregnancy - microparticles - preeclampsia - intrauterine growth restriction

• References

• 1 Heit JA, Silverstein MD, Mohr DN, Petterson TM, Lohse CM, O’Fallon WM, Melton LJ. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86: 452-63.
• 2 Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999; 353: 1258-65.
• 3 Cerneca F, Ricci G, Simeone R, Malisano M, Alberico S, Guaschino S. Coagulation and fibrinolysis changes in normal pregnancy: increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hyper-coagulant state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 1997; 73: 31-6.
• 4 Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small-for-gestational age infants. BJOG 1986; 93: 1049-59.
• 5 Taylor RN, de Groot C, Cho YK, Lim HK. Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia. Semin Reprod Endocrinol 1998; 16: 17-31.
• 6 VanWijk MJ, Kublickiene K, Boer K, Vanbavel ED. Vascular function in preeclampsia. Cardiovasc Res 2000; 47: 38-48.
• 7 Boffa MC, Valsecchi L, Fausto A, Gozin D, D’Angelo SV, Safa O, Castiglioni MT, Amiral J. Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension. Thromb Haemost 1998; 79: 1092-5.
• 8 Austgulen R, Lien E, Vince G, Redman CW. Increased maternal plasma levels of soluble adhesion molecules in preeclampsia. Eur J Obstet Gynecol Reprod Biol 1996; 71: 53-8.
• 9 Felfering-Boehm D, Salat A, Vogl SE, Murabito M, Felferning M, Schmidt D, Mittlboeck M, Husslein P, Mueller MP. Early detection of preeclampsia by determination of platelet aggregability. Thromb Res 2000; 98: 139-46.
• 10 Konijnenberg A, Stokkers EW, van der Prost JA, Schaap MP, Boer K, Bleker OP, Sturk A. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules. Am J Obstet Gynecol 1997; 176: 461-9.
• 11 Sheppard BL, Bonnard J. An ultrastructural study of uteroplacental spiral arteries in hypertensive an normotensive pregnancies complicated by fetal growth retardation. Br J Obstet Gynecol 1974; 83: 695-705.
• 12 Bretelle F, Sabatier F, Blann A, D’Ercole C, Boutiere B, Mutin M, Boubli L, Sampol J, Dignat-George F. Maternal endothelial soluble cell adhesion molecules with isolated small for gestational age fetuses: comparison with preeclampsia. BJOG 2001; 108: 1277-82.
• 13 Bevers EM, Comfurius P, Dekkers DW, Harmsma M, Zwaal RF. Transmembrane phospholipid distribution in blood cells: control mechanism and pathophysiological significance. J Biol Chem 1998; 379: 973-86.
• 14 Barry OP, Pratico D, Lawson JA, Fitzgerald GA. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997; 99: 2118-27.
• 15 Mesri M, Altieri DC. Endothelial cell activation by leukocyte microparticles. J Immunol 1998; 16: 4382-7.
• 16 Combes V, Simon AC, Grau GE. et al In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93-102.
• 17 Katopodis JN, Kolodny L, Jy W. et al Platelet microparticles and calcium homeostasis in acute coronary ischemias. Am J Hematol 1997; 54: 95-101.
• 18 Hughes M, Hayward CP, Warkentin TE, Horsewood P, Chorneyko KA, Kelton JG. Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood 2000; 96: 188-94.
• 19 Laude I, Rongieres-Bertrand C, Boyer-Neumann C, Wolf M, Mairovitz V, Hugel B, Freyssinet JM, Frydman R, Meyer D, Eschwege V. Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight. Thromb Haemost 2001; 85: 18-21.
• 20 Brenner WE, Edelman DA, Hendricks CH. A standard of fetal growth for the United States of America. Am J Obstet Gynecol 1976; 126: 555-64.
• 21 Aupeix K, Hugel B, Martin T, Bischoff P, Lill H, Pasquali JL, Freyssinet JM. The significance of shed membrane particles during programmed cell death in vitro and in vivo in HIV infection. J Clin Invest 1997; 99: 1546-54.
• 22 Teran E, Escudero C, Moya W, Flores M, Vallence P, Lopez-Jamarillo P. Elevated C reactive protein and pro-inflammatory cytokines in Andea women with preeclampsia. Int J Gynaecol Obstet 2001; 75: 243-9.
• 23 Faas MM, Schuiling GA, Baller JFW, Baker WW. Glomerular inflammation in pregnant rats after infusion of low dose endotoxin: an immunohistological study in experimental preeclampsia. Am J Pathol 1995; 147: 1510-8.
• 24 Faas MM, Schuiling GA. Preeclampsia and the inflammatory response. Eur J Obstet Gynecol Reprod Biol 2001; 95: 213-7.
• 25 Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180: 499-506.
• 26 Harlow FH, Brown MA, Brighton TA, Smith SL, Trickett AE, Kwan YL, Davis GK. Platelet activation in the hypertensive disorders of pregnancy. Am J Obstet Gynecol 2002; 187: 688-95.
• 27 Joop K, Berckmans RJ, Nieuwland R. et al Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 2001; 85: 810-20.
• 28 Sheppard BL, Bonnar J. Uteroplacental hemostasis in intrauterine fetal growth retardation. Semin Thromb Hemost 1999; 25: 443-6.
• 29 Holme PA, Solum NO, Brosstad F, Pedersen T, Kveine M. Microvesicles bind soluble fibrinogen, adhere to immobilized fibrinogen and coaggregate with platelets. Thromb Haemost 1998; 79: 389-94.
• 30 Sugimura M, Kobayashi T, Shu F, Kanayama N, Terao T. Annexin V inhibits phosphatidylserine-induced intrauterine growth restriction in mice. Placenta 1999; 20: 555-60.
• 31 Miyamoto S, Kowalska MA, Marcinkiewicz C. et al Interaction of leukocytes with platelet microparticles derived from outdated platelet concentrates. Thromb Haemost 1998; 80: 982-8.
• 32 Sabatier F, Bretelle F, D’Ercole C, Boubli L, Sampol J, Dignat-George F. Neutrophil activation in preeclampsia and isolated intrauterine growth retardation. Am J Obstet Gynecol 2000; 183: 1558-63.
• 33 Barry OP, Pratico D, Savani RC, Fitzgerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998; 102: 136-44.
• 34 Mesri M, Altieri DC. Leukocyte micro-particles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1signaling pathway. J Biol Chem 1999; 274: 23111-8.
• 35 Sabatier F, Roux V, Camoin L, Anfosso F, Sampol J, Dignat-George F. Interaction of endothelial microparticles with monocytic cells in vitro induces a tissue factor-dependent procoagulant activity. Blood 2002; 99 (11) 3962-70.